Dr. Barry Dworkin

New approach to treating metastatic pancreatic adenocarcinoma for people who already had at least one systemic treatment, or who cannot take multi-drug chemotherapy.

Medical Mythbusting Commentary for October 1, 2026

Source:
This Pill Will Change Cancer Treatment Forever

Reference:
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer,

Related posts:

  1. New medication for the treatment of advanced pancreatic cancer increases median overall survival from 6.7 to 13.2 months.
  2. Targeted chemotherapy for HER2 breast cancer patients shows good results in phase 3 study
  3. Pancreatic cancer research given a boost
  4. mRNA-derived pancreatic cancer vaccine demonstrates efficacy in small study. Much more evaluation required for these bespoke vaccines.